Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bundle for SSI Prevention in Laparoscopic Colorectal Surgery
NCT03081962Phase 3Unknown
- Sponsor
- Hospital General Universitario de Elche
- Start
- Feb 2017
- Primary completion
- Aug 2017
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised trial of clindamycin, gentamicin and mupirocin in surgical site infection (SSI) (2 arms), sponsored by Hospital General Universitario de Elche. Primary endpoint: Incisional surgical site infection at 30 days. Status: unknown.
02
Drugs
clindamycingentamicinmupirocin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03081962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081962.